TCTR20161105001招募中未知
Efficacy and safety of an insulin protocol in medical intensive care unit patients
KCMH Hospital Development fund0 个研究点目标入组 50 人开始时间: 2016年11月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •- Have at least 1 episode of hyperglycemia, defined by point of care glucose measurement more than 180 mg/dL
- •- Using intravenous insulin infusion at least 24 hours
排除标准
- •- Type 1 diabetes
- •- pancreatic diabetes mellitus
- •- hyperglycemic crisis patients, i.e diabetic ketoacidosis, hyperglycemic hyperosmolar state
- •- Major Protocol violation
研究者
相似试验
招募中
不适用
Study of the efficacy and safety of insulin degludec who treating with basal insulin glargine or insulin detemir in type 1 diabetes with the Basal-Bolus TherapyType 1 diabetesJPRN-UMIN000012358Toho University School of Medicine, Division of diabetes, metabolism and endocrinology20
招募中
不适用
Study of the efficacy and safety of insulin degludec who treating with basal insulin glargine or insulin detemir in type 2 diabetes with the Basal-Bolus TherapyType 2 diabetesJPRN-UMIN000015792Toho University School of Medicine, Division of diabetes, metabolism and endocrinology40
已完成
不适用
Comparison of the efficacy and safety of insulin degludec/aspart (twice-daily injections), insulin glargine 300 Units/mL and insulin glulisine (Basal plus therapy).diabetesJPRN-UMIN000030648Minami Osaka hospital20
已完成
不适用
Investigation of efficacy and safety of insulin degludec or insulin glargine in type 2 diabetes with basal-bolus therapytype 2 diabetesJPRN-UMIN000013872Juntendo University Graduate School of Medicine60
已完成
不适用
EFFICACY AND SAFETY OF INTENSIVE INSULIN THERAPY WITH INSULIN GLULISINE IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH BASAL INSULIN AND ORAL GLUCOSE-LOWERING DRUGS-E11 Non-insulin-dependent diabetes mellitusNon-insulin-dependent diabetes mellitusE11PER-119-10sanofi-aventis Recherche & Development,20